Display options
Share it on

Obstet Gynecol Int. 2016;2016:6870679. doi: 10.1155/2016/6870679. Epub 2016 Aug 25.

Knowledge of Latin American Obstetricians and Gynecologists regarding Heavy Menstrual Bleeding.

Obstetrics and gynecology international

Luis Bahamondes, Victor Marin, Silvia Ciarmatori, Agnaldo L Silva-Filho, Juan Manuel Acuña, Maria Y Makuch

Affiliations

  1. Department of Obstetrics and Gynecology, University of Campinas Medical School (UNICAMP), Campinas, SP, Brazil.
  2. Bayer HealthCare, Mexico City, Mexico.
  3. Hospital Italiano, Buenos Aires, Argentina.
  4. Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
  5. Florida International University College of Medicine, Miami, Fl, USA.

PMID: 27648073 PMCID: PMC5014946 DOI: 10.1155/2016/6870679

Abstract

Background. Heavy menstrual bleeding (HMB) is a common gynecological complaint affecting quality of life. Objectives. To assess knowledge on diagnosis and treatments of HMB of Latin American (LA) obstetricians and gynecologists (OBGYNs). Methods. A survey was conducted during a scientific meeting, organized to provide updated information on topics of reproductive medicine to OBGYNs from 12 LA countries who were invited to respond to a multiple-choice questionnaire. Results. Of the 210 OBGYNs participating in the survey, from 169 (80.4%) to 203 (96.7%) answered the questions. Most respondents (80%) gave accurate answers regarding the amount of blood loss which defines HMB, underreported the proportion of women who consulted due to HMB, and were aware that the use of combined oral contraceptives (COCs) with ethynyl estradiol is not an adequate treatment in women with HMB. Female OBGYNs and those who worked in the private sector were more prone to report a higher possibility of improvement of HMB with a COC that contained estradiol valerate and dienogest or with a levonorgestrel-releasing intrauterine system. Conclusions. In general, the respondents were aware of the importance of HMB in gynecological practice and of the new medical treatments and underreported the proportion of women who consulted due to HMB.

References

  1. Eur J Med Res. 2013 Jun 21;18:17 - PubMed
  2. Cochrane Database Syst Rev. 2009 Oct 07;(4):CD000154 - PubMed
  3. Eur J Contracept Reprod Health Care. 2011 Aug;16(4):258-69 - PubMed
  4. Health Technol Assess. 2015 Oct;19(88):i-xxv, 1-118 - PubMed
  5. Am J Obstet Gynecol. 2001 Mar;184(4):523-30 - PubMed
  6. Am J Obstet Gynecol. 2013 Dec;209(6):535.e1-535.e14 - PubMed
  7. Acta Obstet Gynecol Scand. 1966;45(3):320-51 - PubMed
  8. Obstet Gynecol Surv. 1980 Oct;35(10):597-618 - PubMed
  9. Contraception. 2009 Nov;80(5):436-44 - PubMed
  10. Int J Womens Health. 2015 May 04;7:485-91 - PubMed
  11. Aust N Z J Obstet Gynaecol. 1991 Feb;31(1):66-70 - PubMed
  12. Am J Obstet Gynecol. 2016 Jan;214(1):31-44 - PubMed
  13. Womens Health (Lond). 2016 Jan;12 (1):15-20 - PubMed
  14. Int J Gynaecol Obstet. 2011 Apr;113(1):3-13 - PubMed
  15. Int J Clin Pract. 2015 Dec;69(12 ):1526-7 - PubMed
  16. Obstet Gynecol. 2010 Oct;116(4):865-75 - PubMed
  17. Contraception. 2012 Nov;86(5):452-7 - PubMed
  18. Obstet Gynecol. 2013 Mar;121(3):632-43 - PubMed
  19. Br J Obstet Gynaecol. 1990 Aug;97(8):690-4 - PubMed
  20. Cochrane Database Syst Rev. 2016 Jan 29;(1):CD003855 - PubMed
  21. Acta Obstet Gynecol Scand. 2014 Jan;93(1):52-7 - PubMed
  22. Proc Nutr Soc. 1977 Dec;36(3):98A - PubMed
  23. Acta Obstet Gynecol Scand. 1966;45:Suppl 7:1-23 - PubMed
  24. Am J Obstet Gynecol. 2013 Sep;209(3):202.e1-7 - PubMed
  25. Br J Obstet Gynaecol. 1991 Aug;98(8):789-96 - PubMed
  26. Haemophilia. 2016 May;22(3):397-402 - PubMed
  27. Int J Womens Health. 2015 Jul 16;7:717-22 - PubMed
  28. Hum Reprod. 2011 Oct;26(10):2698-708 - PubMed
  29. Obstet Gynecol. 2010 Sep;116(3):625-32 - PubMed
  30. F1000Prime Rep. 2015 Mar 03;7:33 - PubMed

Publication Types